Skip to main content

Light-Adjustable Lens™ (LAL)

The light adjustments are painless and non-invasive

Safe and FDA-Approved

2X as likely to achieve 20/20 vision

Customize your vision around the age of 50 with The Light Adjustable Lens™ From RxSight

The first and only intraocular lens (IOL) that allows your physician to optimize your vision, following Refractive lens exchange (RLE) or Refractive lens exchange with cataract (RLE with Cataract). You will be able to preview and compare possible vision outcomes with your doctor based on your personal desires and lifestyle requirements.

Why the Light-Adjustable Lens™ is significant

Traditionally, Refractive lens exchange (RLE) or Refractive lens exchange with cataract (RLE with Cataract) patients would undergo extensive pre-operative testing to determine the prescription (or power) their new implantable lens should be set at. However, pre-op testing cannot fully anticipate small shifts occurring during the healing process. Being able to adjust the lens’ power after healing is complete gives surgeons and patients the opportunity for clearer, more precise vision. The LAL removes the guesswork from Refractive lens exchange (RLE) or Refractive lens exchange with cataract (RLE with Cataract).​

How does it work?

Vision optimization is done by your eye doctor after lens implantation through a series of painless light treatment procedures that precisely reshape your lens. You may need 2 to 4 total light treatments over a period of 1 to 2 weeks to reach your vision goals.

What to expect

The Light Adjustable Lens™ delivers superior vision outcomes that non adjustable IOLs cannot match. Patients are 2x as likely to achieve 20/20 vision without glasses VS. standard (fixed) monofocal IOL1.

The Light Adjustable Lens and Light Delivery Device (LDD) system is indicated for patients who have a Refractive lens exchange (RLE) or Refractive lens exchange with cataract (RLE with Cataract), and need surgery for it, have corneal astigmatism (at least 0.75 diopters) before surgery, and do not have preexisting macular disease.